(NasdaqGM:SWKS), IRVINE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Skyworks Solutions, Inc. (Nasdaq: SWKS), an innovator of high-performance analog and mixed-signal semiconductors connecting people, places and things, will host a conference call with analysts to discuss its fourth quarter fiscal 2025 results and business outlook on Nov. 4, 2025, at 4:30 p.m. EST. After the […]
— The Rise of the Supermanager, the next report in the Josh Bersin Company's AI research series, reframes management for the AI Age — Findings to be unveiled at UNLEASH World, October 20-22, Paris, during Josh Bersin's keynote — Launch includes a new readiness tool and supermanagers course on Galileo Learn™, delivering actionable insights and
Citius Pharmaceuticals Inc. (Nasdaq: CTXR) (“Citius Pharma” or the “Company”), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has entered into definitive agreement for the purchase of an aggregate of 3,973,510 shares of its common stock (or pre-funded warrants in lieu thereof) and accompanying common
Trinity Capital Inc.(Nasdaq: TRIN) (the “Company”), a leading alternative asset manager, today announced the commitment of $15 million in growth capital to Kard Financial, Inc., (“Kard”), a commerce media networkthat helps fintechs and financial institutionsdrive usage, loyalty, and engagement through merchant-specificrewards. https://mma.prnewswire.com/media/1248863/Trinity_Capital_v1_Logo.jpg Kard powers next-generation rewards programs through a flexible, API-first platform that enables financial
Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, and Gene Tools, LLC (Gene Tools) today announced a formal collaboration to broaden access tophosphorodiamidate morpholino oligomers (PMOs), a unique class of oligonucleotide therapeutics with significant potential for treating a broad range of genetic diseases, such as Duchenne muscular dystrophy
With big savings, services that simplify and in-store moments designed to bring families together, Lowe's is helping customers create a memorable holiday season This holiday season, Lowe's is making it easier than ever to bring joy home. With festive experiences, MyLowe's Rewards* and MyLowe's Pro Rewards* member perks, savings beginning October 30 and gifts for
Milestones affirmFlexsys' leadership in sustainability, from top 1% recognition to credible near-term and net-zero emissions reduction targets, and a commitment to 100% sustainable materials by 2040. Flexsys, a global leader in tire additives and solutions, has announced two major milestones in its sustainability journey. The company has been awarded the Platinum medal by EcoVadis in
PaceZero Capital Partners(“PaceZero”) announced today that it has provided Assembly Corp. (“Assembly”) with a $5 million credit facility. The funding will support Assembly as it delivers on its portfolio of development projects across the Greater Toronto Area. https://mma.prnewswire.com/media/2801104/PaceZero_Capital_Partners_Assembly_secures__5_million_Credit_Fac.jpg “Canada needs to increase the availability of quality, affordable homes,” said Jordan Peckham, Founder and CEO of
Creating the industry's first Agentic AI-Powered Client-Tailored intelligence Dataminr, the leader in AI-powered real-time event, threat & risk intelligence, today announced its intent to acquire ThreatConnect, a premier intelligence management platform for contextualizing and prioritizing threats across internal client data environments. The transaction values ThreatConnect at $290 million. https://mma.prnewswire.com/media/2576710/Dataminr_Logo_Logo_V1.jpg The fusion of Dataminr's leading AI
d'Esparbes to lead Antheia's financial strategy as the company continues its global expansionand commercialization Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine supply chains, today announced the appointment of Eric d'Esparbes as Chief Financial Officer. d'Esparbes will oversee Antheia's financial strategy and operations as the company advances its next phase of commercialization and unlocks its